Colgate-Palmolive (NYSE:CL) Shares Purchased by Baader Bank Aktiengesellschaft

Baader Bank Aktiengesellschaft lifted its stake in Colgate-Palmolive (NYSE:CLFree Report) by 50.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,635 shares of the company’s stock after acquiring an additional 1,217 shares during the period. Baader Bank Aktiengesellschaft’s holdings in Colgate-Palmolive were worth $330,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Peak Financial Advisors LLC bought a new position in Colgate-Palmolive during the 4th quarter valued at $1,315,000. Gordian Advisors LLC acquired a new position in Colgate-Palmolive during the third quarter worth about $602,000. Carrera Capital Advisors raised its position in Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after acquiring an additional 7,353 shares in the last quarter. Fiduciary Alliance LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at about $4,066,000. Finally, Vontobel Holding Ltd. boosted its position in shares of Colgate-Palmolive by 224.6% during the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock valued at $82,626,000 after purchasing an additional 550,750 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on CL shares. TD Cowen cut their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Stifel Nicolaus cut their target price on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research report on Friday, January 17th. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Finally, UBS Group dropped their price target on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $102.00.

Get Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $90.96 on Friday. The firm has a market cap of $74.31 billion, a P/E ratio of 26.06, a PEG ratio of 3.59 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30. The stock’s 50-day moving average is $91.58 and its two-hundred day moving average is $97.29.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.20%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is presently 57.31%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.